FC
GOSS icon

FORA Capital’s Gossamer Bio GOSS Stock Holding History

FORA Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,261
Closed -$40K – 1006
2020
Q3 		$40K Hold
3,261
– – 0.03% 476
2020
Q2 		$42K Buy
+3,261
New +$41K 0.01% 671
2020
Q1 		– Sell
-22,833
Closed -$357K – 1148
2019
Q4 		$357K Buy
+22,833
New +$460K 0.04% 475

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

FORA Capital's GOSS Position: Q4 2020 in Review

FORA Capital sold out of Gossamer Bio (GOSS) in Q4 2020, closing a stake of 3,261 shares — an estimated $40K sold.

FORA Capital first reported a position in GOSS in Q4 2019 and held it in 3 quarters. The position peaked at $357K in Q4 2019. 122 funds tracked by Wall St. Rank hold GOSS as of Q4 2020.

  • FORA Capital reported no remaining Gossamer Bio position as of Q4 2020 after selling out during the quarter.
  • FORA Capital sold 3,261 Gossamer Bio shares in Q4 2020, an estimated $40K.
  • FORA Capital first reported a position in Gossamer Bio in Q4 2019 and held it in 3 quarters.
  • FORA Capital's Gossamer Bio position peaked at $357K in Q4 2019.
  • 122 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2020.

Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.